The New Jersey Alliance for
Clinical and Translational Science
Announcements, Deadlines, Reminders
April 26, 2021
|
|
NJ ACTS TL1 Fellowships
April 30, 2021
|
|
Become a TL1 Fellow:
The NJ ACTS TL1 Program is soliciting applications for the 2021-2022 TL1 cohort (August – July). There are 3 predoctoral and 3 postdoctoral fellowship slots available.
This program equips its Fellows with enhanced knowledge, skills, and abilities that provide a broad introduction to clinical and translational research concurrent with their current pre- or postdoctoral research program.
Letter of Intent (LOI) Required: Due April 30, 2021.
Link to LOI REDCap form is available at:
|
|
NJ Workforce Development Core
Grant Writing Group
|
|
The NJ ACTS Workforce Development Core runs a monthly grant writing program with two trained Grant Coaches, Drs. Lauren Aleksunes and Suzie Chen, from the Ernest Mario School of Pharmacy.
Both coaches are trained by the National Research Mentoring Network-CIC Academic Network, a collaborative Big Ten NIH grant offering professional development grantsmanship coaching, and mentor skills training in biological, clinical, environmental, and social/behavioral sciences.
To read more about the Grant Writing Program visit NJ ACTS
|
|
NJ Workforce Development Core
Being an Effective Mentee
Friday, April 30, 2021
|
|
Being an Effective Mentee:
Establishing Your Individual Development Plan
Speaker: Gregory Peck, DO, MPH
This program will inform mentees about the process of developing an Individual Development Plan (IDP). The program is open to RBHS Faculty in all tracks including Associate Professor.
April 30, 2021
12: 00 pm-1:00 pm
|
|
Introducing
Anthony Gonzalez
Manager of Quality Assurance and Quality Control
|
|
Anthony Gonzalez joined the NJ ACTS Admin Team as Manager of Quality Assurance and Quality Control. He provides expertise in clinical research, basic science research, and as an Institutional Review Board Member.
Within clinical research, Anthony has covered the specialties of Oncology, Pediatrics, Radiology, and Cardiology. As a basic science researcher, he worked collaboratively with a local health system to develop novel techniques to detect bacterial pneumonia via vapor samples.
In his free time, he volunteers as an EMT, is an adjunct professor, and enjoys time with his wife and one-year-old daughter.
|
|
NJ ACTS Biostatistics and Epidemiology
Workshop Series
Thursday, May 6, 2021
|
|
An Introduction to the analysis of
RNA sequencing data at multiple scales
Presented by:
Assistant Professor
Department of Biostatistics and Epidemiology
When:
Thursday, May 6, 2021
2:30pm – 4:00pm
Target Audience:
Faculty/Staff/Trainees/Students interested in bioinformatic analysis and computational tools of RNA-seq data
*ALL RESEARCH EXPERIENCE LEVELS WELCOME*
|
|
Welcoming New Co-Lead to
Integrating Special Populations (ISP) Core
Dalton Conley, PhD
|
|
Dalton Conley joined the ISP Core as Princeton co-lead.
Dr. Conley is a distinguished sociologist who has made major contributions to understanding social inequalities in the United States. His work has provided important insights into class advantages and racial inequalities in the U.S., issues that are critical to the challenges facing justice-involved individuals and released prisoners.
He is the Henry Putnam University Professor of Sociology at Princeton University where he is also an affiliate of the Office of Population Research and the Center for Health and Wellbeing. He is also a Research Associate at the National Bureau of Economic Research (NBER). In 2018 he was elected to the National Academy of Sciences.
Professor Dalton has a second Ph.D. in Genetics and works in social genomics, at the intersection of social science and genetics, frequently collaborating with biomedical scientists, and has written an important recent book on the genomic revolution in social science.
His work contributes to the study of social and health inequalities over the life course, integrating genomic factors and resonating with the work of other social scientists on processes of cumulative advantage and disadvantage over the life course.
His addition to NJ-ACTS will help to build research partnerships across NJ-ACTS institution. He will contribute to the service function of the ISP Core, and is already scheduled for a fall webinar. He will bring his sociological and genomic perspectives to research on vulnerable populations including justice-involved individuals; research collaborations are being explored involving use of the large healthcare datasets held at Rutgers.
|
|
Updated Biosketch and Other Support
For due dates on or after May 25, 2021
|
|
Beginning with deadlines on and after May 25, 2021, NIH requires all applicants to submit biosketches that address the new requirements for the Personal Statement, Scientific Appointments and Scholastic Appointments
Other Support has also been changed, requiring additional, detailed information on all current and pending support and the applicant’s signature. The NIH has provided a sample that applicants can follow when requested to submit Other Support.
|
|
Are you interested in collaborating across the RWJBH system or conducting studies at RWJBH facilities? |
|
We encourage all RBHS faculty, undertaking clinical studies, to consider extending those studies to other sites across the RWJBH system. The RBHS Clinical Trials Office can provide coordination with RWJBH and the individual clinical sites to make the processes and approvals required for such collaborations smoother and easier.
If you have questions about collaborating with RWJBH, or if you have a plan to collaborate, you are urged to contact Nancy Reilly, Executive Director of the Clinical Trials Office, as early as possible in the process. reillyna@rbhs.rutgers.edu
|
|
NJ ACTS Special Populations
2021 Webinar Series
Tuesday, May 11, 2021
|
|
Tuesday, May 11, 2021
12:00 pm - 1:00 pm
Medications for Opioid Use Disorder and Peer Health Navigation for Persons Leaving NJ State Prisons and Returning to the Community – Early Findings
Presented By:
Donald (Rusty) Reeves, MD
Peter Treitler, MSW
Risk of relapse and adverse health events is high following prison release, with risk of fatal overdose 129 times greater in the 2 weeks post-release than in the general population. During this seminar, the presenters will discuss early findings from their mixed-methods studies on the implementation and outcomes of two novel interventions to reduce harm: pre-release medication for opioid use disorder and the Intensive Recovery Treatment Support (IRTS) peer health navigator program.
Zoom Link and Flyer Coming Soon!
|
|
Introducing the New Jersey
Practice-Based Research Network
June 3-4, 2021
|
|
The New Jersey Practice-Based Research Network is a new initiative to increase the presence of New Jersey clinical practices in academic research. Join us to mark the launch of the network, bringing together clinicians, researchers, and leaders across the country.
DAY 1: 10 am - 1 pm ET Thursday, June 3, 2021
Welcome:
XinQi Dong, MD, MPH, Director, Rutgers Institute for Health, Health Care Policy and Aging Research & Henry Rutgers Distinguished Professor of Population Health Sciences
Keynotes:
• Shereef Elnahal, MD, MBA, President & CEO, University Hospital Newark & former commissioner, New Jersey Department of Health
• Andy Anderson, MD, President & CEO, RWJBH Medical Group
DAY 2: 10 am - 1 pm ET Friday, June 4, 2021
Welcome:
• Ann M. Nguyen, PhD, MPH, Director, NJPBRN
• Rey A. Panettieri, Jr, MD, Director, Rutgers Institute for Translational Medicine and Science & Vice Chancellor for Translational Medicine and Science, Rutgers University
Keynotes:
• Lawrence Casalino, MD, MPH, PhD, Professor of Population Health Sciences, Weill Cornell Medical College
• Alonzo L. Plough, PhD, MA, MPH, VP, Research-Evaluation-Learning & Chief Science Officer, Robert Wood Johnson Foundation
VIRTUAL EVENT | CME CREDITS AVAILABLE
|
|
Alfred Tallia, MD, MPH, professor and chair of the Department of Family Medicine and Community Health as well as NJ ACTS Community Engagement Core Co-Lead, was elected to a second term as Chair of the National Board of Medical Examiners (NBME).
|
|
Leggett, Susan E.; Hruska, Alex M.; Guo, Ming; Wong, Ian Y. Cell Communication and Signaling, 19, Article number: 32 (2021), 10 March 2021.
|
|
NJ ACTS is a partnership between Rutgers, NJIT and Princeton, NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
|
|
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UL1TR003017 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
UL1TR003017, KL2TR003018 and TL1TR003019
|
|
|
|
|
|
|
|
|
|
